Atomic-scale view of bacterial proteins offers path to new tuberculosis drugs
In studying a cousin of the bacterium that causes tuberculosis, scientists have drawn a molecular map of the target for rifampicin, a common antibiotic. They are now using it in an effort to combat multi-resistant tuberculosis, for which existing treatments don’t work. More »
Source: The Rockefeller University Newswire - Category: Biomedical Science Authors: Tashian Myers Tags: Science News chemical and structural biology Elisabeth Campbell immunology RNA polymerase Seth Darst tuberculosis Virology and Microbiology Source Type: news
More News: Allergy & Immunology | Biology | Biomedical Science | Chemistry | Microbiology | Molecular Biology | Science | Tuberculosis | Virology